Search PDMR transactions

Notifier
Name of person with notification obligation
Hangethe Consulting AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Patrik Fagerholm
Position
Chief Financial Officer (CFO)
Initial notification
No
Amendment
Yes
Details of amendment
Fel instrument rapporterade, kompletterat
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant NextCell Pharma AB TO2 SE0022240800 Exercise decrease 298,440 Quantity 0.00 SEK 30/05/2025 Outside a trading venue
Share NextCell Pharma AB SE0009723125 Exercise increase 298,440 Quantity 1.00 SEK 30/05/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma AB TO2 SE0022240800 Exercise decrease 30/05/2025 Outside a trading venue 298,440 (Quantity) 0.00 SEK
NextCell Pharma AB SE0009723125 Exercise increase 30/05/2025 Outside a trading venue 298,440 (Quantity) 1.00 SEK
<< Back